Work

Supplementary Figure 4 from Network Analysis Identifies an HSP90-Central Hub Susceptible in Ovarian Cancer

Year: 2023

Type: supplementary-materials

Abstract: PDF file - 203KB, Ganetespib and paclitaxel inhibit ovarian cancer growth in vivo.

DOI: 10.1158/1078-0432.22451628.v1

Authors: Hanqing Liu, Fang Xiao, Ilya G. Serebriiskii, Shane W. O'Brien, Marisa A. Maglaty, Igor Astsaturov, Samuel Litwin, Lainie P. Martin, David A. Proia, Erica A. Golemis, Denise C. Connolly

Language: English

Topic: Ovarian cancer diagnosis and treatment

Subfield: Reproductive Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4361909508

Cites:

Cited by:

Related to: 10